Abstract
Epidemiological studies have shown that dietary antioxidant consumption is inversely associated with the development of coronary artery disease. The precise mechanisms that underlie these observations, however, are not clear. While the beneficial effects of antioxidants have been attributed to the prevention of oxidative modification of low-density lipoprotein (LDL) and the inhibition of atherogenesis, other factors may also be important. Platelet fonction is dependent upon the balance between oxidative stress and antioxidant protection and, importantly, platelets have been implicated in the development of atherosclerosis, as well as in the acute occlusion of coronary vessels (1,2).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Davies MJ, Thomas AC: Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984; 310:1137.
David M. A macro and micro view of coronary vascular insult with ischemic heart disease. Circulation. 1990;82:1–138.
DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocrdial infarction. N Engl J Med. 1980;303:897.
Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699.
Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombis. Brit Heart J. 1983;1983:127.
de Graff JC, Banga JD, Moncada S, Palmer RMJ, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 1992;85:2284.
Radomski MW, Palmer MJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophysic Res Comm. 1987;148:1482.
Santol MT, Valles J, Marcus AJ, Safier M, Brodkman J, Islan N, Ullman HL, Eirosa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest. 1991;87:571.
Fitzgerald DJ, Roy L, Catella F, FitzGerald GA: Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983.
The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990;336:827.
Antiplatelet Trialists Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and sroke by prolonged antiplatelet therapy in various categories of patients. Brit Med J. 1994;308:81.
Riemersma RA, Wood DA, Macintyre CCH, Elton RA, Gey KF, Oliver MF: Risk of angina pectoris and plasma concentrations of vitamins A, C, E, and carotene. Lancet. 1991;337:1.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Eng J Med. 1993;328:1444.
Buczynski AB, Wachowicz B, Dedziora-Kornatowska K, Tkaczewski W, Kedziora J. Changes in antioxidant enzyme activities, aggregability, and malonyldialdehyde concentrations in blood platelet from patients with coronary heart disease. Atherosclerosis. 1993;100:223.
Bressler N, Broekman M, Marcus A. Concurrent studies of oxygen consumption and aggregation in stimulated human platelets. Blood. 1979;53:167.
Burch JW, Burch PT: Glutathione disulfide production during arachidonic acid oxygenation in human platelets. Prostaglandins. 1990;39:123.
Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest. 1977;59:149.
Freedman JE, Keaney JF, Jr.: NO and Superoxide detection in human platelets. In: Packer L, ed. Nitric Oxide, Part C: Biological and Antioxidants Activities. Vol 301. San Diego, CA: Academic Press, 1998.
Handin RI, Karabin R, Boxer GJ: Enhancement of platelet function by Superoxide anion. J Clin Invest. 1987;59:149.
Stuart M, Holmsen H. Hydrogen peroxide, an inhibitor of platelet function: effect on adenine nucleotide metabolism, and the release reaction. Am J Hematol. 1977;2:53.
Handin RI, Karabin R, Boxer GJ: Enhancement of platelet function by Superoxide anion. J Clin Invest. 1977;59:959.
Rodvien R, Lindon J, Levine P. Physiology and ultrastructure of the blood platelet following exposure to hydrogen peroxide. Brit J Haematol. 1976;33:19.
Irani K, Pham Y, Coleman LD, Roos C, Cooke GE, Miodovnik A, Karim N, Wildhide CC, Goldscmidt-Clermont PJ. Priming of platelet α1β3 by oxidants is associated with tyrosine phosphorylation of β3. Arterioscler Thromb Vasc Biol 1998;18:1698.
Marcus A. Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin Hamatol. 1979;16:188.
Kooy M, Akkerman W, Van Asbeck S, Borghuis L, Van Prooijen H. UVB radiation exposed fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen speces. Brit J Haematol. 1992;83:253.
Calzada C, Vericei E, Lagarde M. Decrease in platelet reduction glutathione increases lipoxygenase activity and decreasee vitamin E. Lipids. 1991;26:696.
Vatassery G, Smith W, Quack H. Ascorbate acid, glutathione and synthetic antioxidants prevent the oxidation of vitamin E in platelets. Lipids. 1989;24:1043.
Chan AC, Tran K, Raynor T, Ganz PR, Chow CK: Regeneration of vitamin E in human platelets. J Biol Chem. 1991;266:17290.
Schiavon R, Freeman G, Guidi G, Perona G, Zatti M, Kakkar V. Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement. Thrombosis Res. 1984;34:389.
Schoene N, Morris V, Levander O. Altered arachidonic acid metabolism in platelets and artas from selenium-deficient rats. Nutrtion Res. 1986;6:75.
Johnson M, Ramey E, Ramwell P. Sex and age differences in human platelet aggregation. Nature. 1975;253:355.
Vericel E, Rey C, Calzada C, Haond P, Capuy P, Lagarde M. Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins. 1992;43:75.
Blache D. Involvement of hydrogen and lipid peroxidase in acute tobacco smoking-induced platelet hyperactivity. Am J Physiol. 1995;268:H679.
The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cander and other cancers in male smokers. N Engl J Med. 1994;330:1029.
Higashi O, Kikuchi Y: Effects of vitamin E on the aggregation and the lipid peroxidation of platelets exposed to hydrogen peroxide. Tohoku J Exp Med. 1974;112:271.
Steiner M, Anastasi J: Vitamin E: an inhibitor of the platelet release reaction. J Clin Invest. 1976;57:732.
Jandak J, Steiner M, Richardson P. Alpha-tocopherol, an effective inhibitor of platelet adhesion. Blood. 1982;73:141.
Steiner M: Effect of α-tocopherol administration on platelet function in man. Thromb Haemost. 1983;49:73.
Baldassare JJ, Henderson P, Burns D, Loomis C, Fischer GJ: Translocation of protein kinase C isoenzymes thrombin-stimulated human platelets — correlation with 1,2 diacylglycerol levels. J Biol Chem. 1992;267:15585.
Kroll MH, Heliums JD, Guo Z, Durante W, Razdan D, Hrbolich JK, Schafer AI: Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem. 1993;268:3520.
Mahoney CW, Azzi A: Vitamin E inhibits protein kinase C activity. Biochem Biophys Res Commun. 1988;154:694.
Freedman JE, Farhat JH, Loscalzo J, Keaney JF, Jr.: α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation. 1996;94:2434.
Stamler J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J. N-Acetylcysteine potentiates platelet inhibition by enodhtleium-derived relaxing factor. Circ Res. 1989;65:789.
Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J: Flow stimulates endothelial cells to release nitrovasodilator that is potentiated by reduced thiol. Am J Physiol. 1990;259:H804.
Shultz PJ, Raij L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992;90:1718.
Michelson AD, Benoit SE, Furman MI, Breckwoldt WL, Rohter MJ, Barnard MR, Loscalzo J: Effects of endotheium-derived relaxing factor/nitric oxide on platelet surface glycoproteins. Am J Physiol. 1996;39:H1640.
Mehta JL, Chen LY, Kone BC, Mehta P, Turner P: Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med. 1995; 125:370.
Sase K, Michel T: Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995;57:2049.
Chen LY, Mehta JL: Variable effects of L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J Pharmacol Exp Ther. 1996;267:253.
Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, Creager MA: Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharmacol. 1995;26:339.
Bodzenta-Lukaszyke A, Gabryelewicz A, Lukaszyke A, Bielawiec M, Konturek JW, Domschke W. Nitric oxide synthase inhibition and platelet function. Thromb Res. 1994;75:667.
Zhou Q, Hellermann GR, Solomonson LP: nitric oxide release from resting human platelets. Thromb Res. 1995;77:87.
Malinski T, Radomski MW, Taha Z, Moncada S: Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Comm. 1993;194:960.
Radomski MW, Palmer RMJ, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 1990;87:5193.
Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Jr., Michelson AD: Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest. 1997; 100:350.
Freedman JE, Ting B, Hankin B, Loscalzo J, Keaney JF, Jr., Vita JA: Impaired platelet production of nitric oxide predicts the presence of acute coronary syndromes. Circulation. 1998;In press.
Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 1986; 170.
Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491.
Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest. 1993;91:2546.
Lynch SM, Frei B: Mechanisms of copper-and iron-dependent oxidative modification of human low-density lipoprotein. J Lipid Res. 1993;34:1745.
Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA: Nitric oxide regulation of Superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. 1994;269:26066.
Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454.
Kissner R, Nauser T, Bugnon P, Lye PG, Koppenol WH: Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chemical Res Toxicol. 1997;10:1285.
Meng YY, Trachtenburg J, Ryan US, Abendschein DR: Potentiation of endogenous nitric oxide with Superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arteries. J Am Coll Cardiol. 1995;25:269.
Ikeda H, Koga Y, Od T, Kuwano K, Nakayama H, Ueno T, Toshima H, Michael L, Entman M. Free oxygen radicals contribute to plattet aggregation and cyclic flow variations in stenosed and endothelium-injred canine coronary arteries. J Am Coll Cardiol. 1994;24:1749.
Freedman JE, Frei B, Welch GN, Loscalzo J: Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest. 1995;96:394.
Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD: Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest. 1996;97:979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Freedman, J.E. (2000). Oxidants and Antioxidants in Platelet Function. In: Keaney, J.F. (eds) Oxidative Stress and Vascular Disease. Developments in Cardiovascular Medicine, vol 224. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4649-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4649-8_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7103-8
Online ISBN: 978-1-4615-4649-8
eBook Packages: Springer Book Archive